Pathstone Holdings, LLC Moderna, Inc. Transaction History
Pathstone Holdings, LLC
- $22.2 Billion
- Q4 2024
A detailed history of Pathstone Holdings, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Pathstone Holdings, LLC holds 12,897 shares of MRNA stock, worth $435,402. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,897
Previous 15,677
17.73%
Holding current value
$435,402
Previous $1.05 Million
48.81%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
925Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.36 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.31 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$863 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$593 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$247 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...